[go: up one dir, main page]

LV10098A - Metilpiperazinazepina atvasinajumi to iegusana un lietosana - Google Patents

Metilpiperazinazepina atvasinajumi to iegusana un lietosana

Info

Publication number
LV10098A
LV10098A LV920398A LV920398A LV10098A LV 10098 A LV10098 A LV 10098A LV 920398 A LV920398 A LV 920398A LV 920398 A LV920398 A LV 920398A LV 10098 A LV10098 A LV 10098A
Authority
LV
Latvia
Prior art keywords
derivatives
methylpiperazinepeptin
acquisition
methylpiperazinoazepine
preparation
Prior art date
Application number
LV920398A
Other languages
English (en)
Other versions
LV10098B (en
Inventor
Jean-Francois Fernand Liegeois
Jacques Elie Delarge
Original Assignee
Therabel Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Research Sa filed Critical Therabel Research Sa
Publication of LV10098A publication Critical patent/LV10098A/lv
Publication of LV10098B publication Critical patent/LV10098B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D517/00Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
    • C07D517/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
LVP-92-398A 1990-09-26 1992-12-23 Methylpiperazinoazepine derivatives, preparation and use thereof LV10098B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
BE9000914A BE1004596A4 (fr) 1990-09-26 1990-09-26 Derives de methylpiperazinoazepine, leur preparation et leur utilisation.
CA002120229A CA2120229C (fr) 1990-09-26 1991-10-10 Derives de methylpiperazinoazepine, leur preparation et leur utilisation
PCT/BE1991/000073 WO1993007143A1 (fr) 1990-09-26 1991-10-10 Derives de methylpiperazinoazepine, leur preparation et leur utilisation
HK98106195A HK1006970A1 (en) 1990-09-26 1998-06-23 Methylpiperazinoazepine derivatives their preparation and use

Publications (2)

Publication Number Publication Date
LV10098A true LV10098A (lv) 1994-05-10
LV10098B LV10098B (en) 1994-10-20

Family

ID=27159764

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-398A LV10098B (en) 1990-09-26 1992-12-23 Methylpiperazinoazepine derivatives, preparation and use thereof

Country Status (14)

Country Link
EP (1) EP0607129B1 (lv)
AT (1) ATE126799T1 (lv)
BE (1) BE1004596A4 (lv)
CA (1) CA2120229C (lv)
DE (1) DE69112432T2 (lv)
DK (1) DK0607129T3 (lv)
EE (1) EE02942B1 (lv)
ES (1) ES2080336T3 (lv)
GR (1) GR3017951T3 (lv)
HK (1) HK1006970A1 (lv)
LT (1) LT3231B (lv)
LV (1) LV10098B (lv)
RU (1) RU2111966C1 (lv)
WO (1) WO1993007143A1 (lv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700445A (en) * 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
FR2850654A1 (fr) * 2003-02-03 2004-08-06 Servier Lab Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1913900B (zh) * 2003-12-22 2010-11-24 阿卡蒂亚药品公司 作为毒蕈碱激动剂的氨基取代的二芳基[a,d]环庚烯类似物及神经精神疾病的治疗方法
CN101962369A (zh) 2003-12-22 2011-02-02 阿卡蒂亚药品公司 氨基取代的二芳基[a,d]环庚烯类似物作为毒蕈碱激动剂的用途及神经精神疾病的治疗方法
CN102807574B (zh) * 2011-05-30 2015-09-02 长春吉大天元化学技术股份有限公司 新型吡啶并硫氮七元环衍生物作为抗肿瘤药物、及其制备方法和应用
CN107382907A (zh) * 2017-06-21 2017-11-24 温州医科大学 一种11‑甲基二苯并[b,f][1,4]硒吖庚因化合物及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7403657A (lv) * 1973-03-23 1974-09-25
US3872122A (en) * 1973-04-16 1975-03-18 Bristol Myers Co 11 H-Pyrimido{8 4,5-b{9 {8 1,4{9 benzodiazepines
GB1587128A (en) 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
IT7851496A0 (it) * 1977-10-31 1978-10-13 Sandoz Ag Menti pirazinobenzossazepine loro preparazione e loro impiego quali medica
CH643263A5 (de) * 1979-05-11 1984-05-30 Sandoz Ag Benzodiazepine, ihre herstellung und verwendung.
GB8819059D0 (en) * 1988-08-11 1988-09-14 Lilly Industries Ltd Benzodiazepine compounds & their use as pharmaceuticals
US4940704A (en) 1989-08-16 1990-07-10 Hoechst-Roussel Pharmaceutical Inc. Pyrido[3,4-b][1,4]benzoxazepines

Also Published As

Publication number Publication date
DE69112432T2 (de) 1996-02-01
CA2120229A1 (fr) 1993-04-15
WO1993007143A1 (fr) 1993-04-15
BE1004596A4 (fr) 1992-12-22
LT3231B (en) 1995-04-25
EE02942B1 (et) 1996-10-15
DE69112432D1 (de) 1995-09-28
RU2111966C1 (ru) 1998-05-27
ES2080336T3 (es) 1996-02-01
LTIP378A (en) 1994-09-25
DK0607129T3 (da) 1995-12-18
CA2120229C (fr) 2002-04-09
EP0607129B1 (fr) 1995-08-23
GR3017951T3 (en) 1996-02-29
HK1006970A1 (en) 1999-03-26
ATE126799T1 (de) 1995-09-15
EP0607129A1 (fr) 1994-07-27
LV10098B (en) 1994-10-20

Similar Documents

Publication Publication Date Title
SE9103572D0 (sv) Organic salts of n,n'-diacetyl cystine
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
SE8900192D0 (sv) Dideoxididehydrokarbocykliska nukleosider
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
DE3683922D1 (de) Chinolinderivate.
GB1544872A (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
YU78092A (sh) Postupak za dobijanje derivata beta-fenilizoserina i njihova primena
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
LV10098A (lv) Metilpiperazinazepina atvasinajumi to iegusana un lietosana
SE7811455L (sv) 2-imino-imidazolidin-derivat
FI833200A0 (fi) Isokinolinderivat, foerfaranden foer deras framstaellning, pao dessa foereningar baserade farmaceutpreparat och deras anvaendning
DK0628042T3 (da) Serotoninerge ergolinderivater
FI864003A (fi) Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar.
ES505896A0 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina
DK0483063T3 (da) Ergolinderivater
FI911616A (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.